PhoreMost and ThinkCyte partner to develop AI-based drug discovery
The partnership combines systems in order to identify subtle phenotypic changes in living cells - News - PharmaTimes
Stay updated with breaking news from Ghost Cytometry. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The partnership combines systems in order to identify subtle phenotypic changes in living cells - News - PharmaTimes
/PRNewswire/ -- PhoreMost Ltd. and ThinkCyte K.K. today announced a strategic research partnership aimed at advancing modern phenotypic drug screening using...
/PRNewswire/ -- Vision Care Group and ThinkCyte today announced a research partnership aimed at advancing cell therapy in retinal disease. The partnership...
/PRNewswire/ -- Vision Care Group and ThinkCyte today announced a research partnership aimed at advancing cell therapy in retinal disease. The partnership...
/PRNewswire/ -- ThinkCyte Inc., a biotechnology company pioneering novel cell analysis and sorting instruments, announced today the launch of their Premier...